Biotech

PENSRUS PENS Rocks the AMC Music Fest in Just 9 Days to Raise Awareness and Funding for ARTHROGRYPOSIS MULTIPLEX CONGENITA (AMC)

NEW YORK, NY: ...

Alchemia Limited Provides Company Update

BRISBANE, AUSTRALIA: ...

The 14th Annual BioEquity Europe Conference Features 96 Innovator Companies With Differentiated Products, Upcoming Milestones and Partner-Ready Assets

REDWOOD CITY, CA: Plenary Sessions Led by Industry Leaders in the Life Sciences Anchor 2 Days of Thought Provoking Program ...

Chicago Bears Quarterback Jay Cutler in Talks With Bio-Solutions Corp-UPDATE

CHICAGO, ILLINOIS: ...

Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer

TUSTIN, CA: Phase III Registration Trial of Investigational Immunotherapy Expected to Start by Year-End ...

Genetic Technologies Executes Agreement With MultiPlan, Inc., a Nationwide Provider Network

MELBOURNE, AUSTRALIA: ...

Aeolus Strengthens Board of Directors With Oncology, Government Contracting and Financial Industry Veterans

MISSION VIEJO, CA: ...

Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2013

HALIFAX, NOVA SCOTIA: ...

Peregrine Pharmaceuticals' Immunotherapy Bavituximab to Be Highlighted in Three Clinical Data Presentations at 2013 ASCO Annual Meeting

TUSTIN, CA: Presentations Include Data From Two Phase II Bavituximab Trials in Second-Line NSCLC and Pancreatic Cancer and a Phase I Bavituximab Trial in HER2-Negative Breast Cancer ...

Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace

TORONTO, ONTARIO: ...